Partner Organisations

PSI is one of many organisations that are rooted within statistics and data analytics.  As such, we believe that it is important for us to link with other appropriate organisations.

PSI is the association located in the UK for statisticians in the pharmaceutical industry, and therefore we have two representatives on the European Federation of Statisticians in the Pharmaceutical Industry council.  EFSPI brings together representatives of statistical associations within Europe.

PSI has a joint award for Statistical Excellence within the Pharmaceutical Industry with the RSS.  There are six-monthly meetings between representatives of both organisations to maintain good communication and identify opportunities to work together.

Recently PSI has linked with the Indian Association for Statistics in Clinical Trials (IASCT) and members of IASCT can join PSI at a reduced rate. PSI also welcomes members from any other countries, and from statisticians working in the wider clinical research and healthcare industries.

PSI has representatives on the Council of Biopharmaceutical Statisticians.

The Special Interest Groups include suitable representatives from, and interacts with, other organisations depending on the SIG topic.  For instance, the Data Transparency SIG has had discussions with PhUSE members.

The PSI Careers and Academic Liaison Committee (CALC) promotes careers for statisticians and programmers within the pharmaceutical industry, and provides information and insights for those who might want to consider such a career through school and university activities, establishing links with relevant professional groups and via our Careers and Schools/Education websites.

The PSI Regulatory Committee is a joint PSI/EFSPI Committee which aims to provide an industry viewpoint on regulatory issues linked to statistics. This includes promoting best practice, reviewing and collating comments on regulatory policy and guidelines, driving debate on future guidance, and engaging with statisticians in European regulatory agencies, including the EMA Biostatistics Working Party (BSWP), as well as the statistical assessors at the Medicines & Healthcare products Regulatory Agency (MHRA).

PSI recognises that it is part of a wide community and therefore actively engages with the community.



Upcoming Events

PSI VisSIG Wonderful Wednesdays

Our monthly webinar explores examples of innovative data visualisations relevant to our day to day work. Each month a new dataset is provided from a clinical trial or other relevant example, and participants are invited to submit a graphic that communicates interesting and relevant characteristics of the data.

PSI VisSIG Webinar: Rapid Insights to Data

The field of data visualization is the intersection of data journalism, statistics, graphic design, computer science, neuroscience, and cognitive psychology. We will focus on the latter two fields of data visualization as it relates to data visualization: neuroscience and cognitive psychology.

PSI One-Day Meeting: Non-proportional hazards and applications in immuno-oncology

Hear about potential strategies to handle non-proportional hazards and delayed treatment effects from experts in the field.

PSI One-Day Meeting: Missing Data in Clinical Trials - Past, Present and Future

At this meeting we will present the evolution of missing data approaches, looking at how they have been handled in the past, the current established missing data approaches and the impact of the new ICH E9 R1 addendum on the handling of missing data, focussing in particular on the treatment policy estimand.

PSI Training Course: R for SAS Users

R is quickly gaining popularity within the pharmaceutical industry due to it being a very powerful object-orientated language, and is able to produce analyses and high quality graphics. This will be a hands-on interactive course and will utilise the RStudio Cloud development environment.

PSI Webinar: Oncology Ted Talks (with interaction)

The format of this event will include Ted Talks by all of our speakers with the opportunity for us to have a discussion together after each of the presentations.

PSI EIWG Webinar: Estimands in Oncology - How and Why

A year on after the final ICH E9 estimands addendum was published, we bring estimands to life. Members of the Estimands in Oncology special interest group will describe how the estimand framework provides a common language to describe the diversity of patient journeys and why it is important to address the right question in clinical trials.

PSI Training Course: Data Monitoring Committees (DMCs)

This course will cover the essentials of DMC set up (roles and responsibilities, DMC charter, practical considerations), as well as discussing DMC case studies and the role of DMCs in adaptive trials and during the pandemic. In addition, there will be an interactive DMC workshop.

Latest Jobs

Biostatistician Project Leader

As a statistician in the Biostatistics and Programming Department, you will be responsible for the methodological and statistical aspects of projects in early clinical development in order to optimize the early development plan and ensure its coherence.

Director of Statistics

As a Director of Statistics, you will be accountable for guiding statisticians in their work, performing senior review of documentation and output deliveries, providing oversight and advising on best practices approach to statistics for clinical trials.

Senior Biostatistician

This position provides expert statistical input and project management for statistical activities in relation to clinical trials and statistical activities executed by the Consumer Healthcare division